These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 1848495
1. False-positive Tc-99m pentavalent DMSA uptake in the imaging of medullary carcinoma of the thyroid. Lette J, Monier D, Ledoux R, Levasseur A. Clin Nucl Med; 1991 Feb; 16(2):136-7. PubMed ID: 1848495 [No Abstract] [Full Text] [Related]
2. Pentavalent Tc-99m DMSA accumulation in a medullary carcinoma of the thyroid. Hirano T, Otake H, Watanabe N, Oriuchi N, Fukuda T, Endo K. Clin Nucl Med; 1997 May; 22(5):339-40. PubMed ID: 9152545 [No Abstract] [Full Text] [Related]
3. Tc-99m-(V)-DMSA: the new sensitive and specific radiopharmaceutical for imaging metastases of medullary thyroid carcinomas? Becker W, Börner W, Reiners C. Horm Metab Res Suppl; 1989 May; 21():38-42. PubMed ID: 2553574 [Abstract] [Full Text] [Related]
4. Technetium-99m-pentavalent dimercaptosuccinic acid uptake in Hurthle cell tumor of the thyroid. Vergara E, Lastoria S, Varrella P, Lapenta L, Salvatore M. J Nucl Biol Med (1991); 1993 Jun; 37(2):65-8. PubMed ID: 8396979 [Abstract] [Full Text] [Related]
5. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome. Adams BK, Fataar A, Byrne MJ, Levitt NS, Matley PJ. J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305 [Abstract] [Full Text] [Related]
6. Imaging with pentavalent [99mTc]DMSA in patients with medullary cancer of the thyroid. Hilditch TE, Murray T, Connell JM, McLellan AR, Reed NS. J Nucl Med; 1988 Oct; 29(10):1746-7. PubMed ID: 2845025 [No Abstract] [Full Text] [Related]
13. More on [99mTc](V)DMSA scintigraphy in patients with medullary carcinoma of the thyroid. Mojiminiyi OA, Udelsman R, Shepstone BJ, Dudley NE, Soper ND. J Nucl Med; 1989 Aug; 30(8):1420. PubMed ID: 2547036 [No Abstract] [Full Text] [Related]
14. The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid. Clarke SE, Lazarus C, Mistry R, Maisey MN. Br J Radiol; 1987 Nov; 60(719):1089-92. PubMed ID: 2825895 [Abstract] [Full Text] [Related]
16. Pentavalent Tc-99m DMSA scintigraphy. Prospective evaluation of its role in the management of patients with medullary carcinoma of the thyroid. Mojiminiyi OA, Udelsman R, Soper ND, Shepstone BJ, Dudley NE. Clin Nucl Med; 1991 Apr; 16(4):259-62. PubMed ID: 1646098 [Abstract] [Full Text] [Related]
17. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid. Clarke SE, Lazarus CR, Wraight P, Sampson C, Maisey MN. J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723 [Abstract] [Full Text] [Related]
20. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid. Ugur O, Kostakğlu L, Güler N, Caner B, Uysal U, Elahi N, Haliloğlu M, Yüksel D, Aras T, Bayhan H, Bekdik C. Eur J Nucl Med; 1996 Oct; 23(10):1367-71. PubMed ID: 8781142 [Abstract] [Full Text] [Related] Page: [Next] [New Search]